OmniComm Systems Signs Multi-Million Dollar, Five Year Agreement with Top 5 US Medical Research University

FORT LAUDERDALE, Fla., Aug. 02, 2016 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced that one of the top 5 medical research universities in the US, selected OmniComm TrialMaster® EDC and related services to conduct a series of clinical studies over a five year period. 

OmniComm TrialMaster EDC was selected from a broad field of competitors for its inherent flexibility, scalability, data quality, and broad capabilities.  Realizing the benefits of eSource is an important initiative for this academic research center.  OmniComm’s expertise and know-how integrating electronic medical record (EMR) systems with TrialMaster EDC was an important factor in the decision.  TrialMaster EDC will integrate with their EMR system, enabling a comprehensive eSource solution. Data captured from the EMR will be automatically imported into the clinical study in TrialMaster, speeding the process of data capture and reducing errors. OmniComm will use the Retrieve Form for Data-capture (RFD) integration profile that was co-developed by CDISC and Integrating the Healthcare Enterprise (IHE), a healthcare interoperability enabler.

“We are proud to partner with one of the nation’s leading academic medical research institutes, providing the most advanced EDC and eSource technology to accelerate their medical research efforts,” said Kuno van der Post, SVP of business development, OmniComm. “TrialMaster EDC is built-for-purpose to run the full array of clinical studies, regardless of complexity, at scale and with the highest level of performance. TrialMaster EDC was deemed to be the best fit for this challenging environment from a broad selection of systems.”